BIAFW (STOCKS)
bioAffinity Technologies, Inc. Warrant
$0.190300
+0.050100 (+35.73%)
Prev close: $0.140200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Maria Zannes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 57
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.66M |
| Benefits Costs and Expenses | $21.50M |
| Costs And Expenses | $21.50M |
| Nonoperating Income/Loss | -$4.28M |
| Operating Expenses | $17.22M |
| Selling, General, and Administrative Expenses | $10.70M |
| Depreciation and Amortization | $464.77K |
| Research and Development | $1.37M |
| Other Operating Expenses | $4.69M |
| Operating Income/Loss | -$11.56M |
| Income/Loss From Continuing Operations After Tax | -$15.88M |
| Income/Loss From Continuing Operations Before Tax | -$15.84M |
| Net Income/Loss | -$15.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.83 |
| Diluted Earnings Per Share | -$6.83 |
| Basic Average Shares | 30,499,126 |
| Diluted Average Shares | 30,499,126 |
| Assets | $7.95M |
| Current Assets | $4.34M |
| Inventory | $77.89K |
| Other Current Assets | $4.26M |
| Noncurrent Assets | $3.60M |
| Fixed Assets | $246.85K |
| Intangible Assets | $702.22K |
| Other Non-current Assets | $2.65M |
| Liabilities | $4.28M |
| Current Liabilities | $3.18M |
| Accounts Payable | $836.21K |
| Wages | $1.72M |
| Other Current Liabilities | $629.07K |
| Noncurrent Liabilities | $1.10M |
| Equity | $3.66M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.66M |
| Liabilities And Equity | $7.95M |
| Net Cash Flow From Operating Activities | -$10.91M |
| Net Cash Flow From Operating Activities, Continuing | -$10.91M |
| Net Cash Flow From Investing Activities | -$15.45K |
| Net Cash Flow From Investing Activities, Continuing | -$15.45K |
| Net Cash Flow From Financing Activities | $13.58M |
| Net Cash Flow From Financing Activities, Continuing | $13.58M |
| Net Cash Flow | $2.65M |
| Net Cash Flow, Continuing | $2.65M |
| Comprehensive Income/Loss | -$15.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.88M |
| Other Comprehensive Income/Loss | $0.00 |